B. Legallicier

870 citations
25 papers · 589 · h-index 11

Impact in

  • Nephrology top 5%
    • Dialysis and Renal Disease Management
    • Renal Diseases and Glomerulopathies
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Renal Diseases and Glomerulopathies 3
    • Dialysis and Renal Disease Management 2
    • Venous Thromboembolism Diagnosis and Management 3

B. Legallicier

25 papers receiving 554 citations

Peers

B. Legallicier
Comparison fields: 5 of 56
  • Nephrology 184
  • Infectious Diseases 92
  • Transplantation 16
  • Pulmonary and Respiratory Medicine 125
  • Genetics 24
Replace Amir M. Kolta with:
Amir M. Kolta France
Anissa Moktefi France
Zübeyde Nur Özkurt Türkiye
Shikha Wadhwani United States
Shamir R Mehta Canada
Razvan Diaconescu United States
Harish Shanthanu Seethapathy United States
Judith Behrens United Kingdom
Guangtao Li China
Henrik Riska Finland
B. Legallicier relative to Amir M. Kolta France Amir M. Kolta's profile →
Citations per field
00.5×2×4×6×8.9×
Amir M. Kolta · 1×
Citations per year

Countries citing papers authored by B. Legallicier

Since Specialization
Citations

This map shows the geographic impact of B. Legallicier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Legallicier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Legallicier more than expected).

Fields of papers citing papers by B. Legallicier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Legallicier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Legallicier. The network helps show where B. Legallicier may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Legallicier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Legallicier Line = papers co-authored together B. Legallicier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020112
2 199878
3
Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
201169
4 200750
5 200145
6 201544
7 201541
8 199529
9 202224
10 201016
11 200813
12 201411
13 199610
14
The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells.
199610
15 19969
16 20169
17
[Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis].
19955
18
[Toxic effect of two antitumoral agents derived from platinum, the cisplatin and the oxaliplatin on primary cultures of proximal tubular cells of the kidney in rabbits].
19933
19
[Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
19953
20 19932

About B. Legallicier

B. Legallicier is a scholar working on Nephrology, Internal Medicine, Pharmacology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 589 indexed citations. Recurring topics across this work include Vasculitis and related conditions (4 papers), Renal Diseases and Glomerulopathies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmaceutical studies and practices (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Dialysis and Renal Disease Management (2 papers). The work is most often cited by research in Nephrology (184 citations), Infectious Diseases (92 citations), Transplantation (16 citations), Pulmonary and Respiratory Medicine (125 citations) and Genetics (24 citations). B. Legallicier has collaborated with scholars based in France, United Kingdom and Switzerland. Frequent co-authors include F Mignon, Pascal Auquier, Béatrice M. Viron, J.-P. Baguet, Stéphane Robitail, Pierre Marie Ronco, Michel Godin, Arnaud François, Gillian Murphy and Brigitte Lelongt. Their work appears in journals such as Nephrology Dialysis Transplantation, Journal of the American Society of Nephrology, Kidney International, The Lancet and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact